HCA Healthcare Inc
HCA: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$515.00 | Wyzkyjc | Vzklbbkfd |
HCA Earnings: Strong Start to 2024, but Management Merely Maintains Guidance
Narrow-moat HCA Healthcare turned in better-than-anticipated first-quarter results that benefited from improving medical utilization trends. However, the company merely maintained its guidance for the full year, which appears to have disappointed the market. Considering that our expectations remain within current guidance ranges, we are not changing our $285 fair value estimate, and we continue to view HCA shares as about fairly valued.